Journal
CURRENT OPINION IN PSYCHIATRY
Volume 32, Issue 4, Pages 275-281Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/YCO.0000000000000518
Keywords
cocaine use disorders; medications; therapy; treatments
Categories
Funding
- Center of Excellence in Substance Addiction Treatment and Education at VA Puget Sound Healthcare System
Ask authors/readers for more resources
Purpose of review Cocaine is a highly addictive substance with serious medical and mental health consequences. Despite these concerns, there are no Food and Drug Administration-approved medications for the treatment of cocaine use disorder (CUD). Although many medication-assisted treatments (MATs) have been investigated, no clear guidelines exist for clinicians treating patients with CUDs. Recent findings There are a limited number of recent data examining MATs for CUD. Multiple high-quality reviews of existing literature have been performed with psychostimulants, modafinil, bupropion, topiramate and disulfiram showing the most promise. Evidence is limited by heterogeneity of studies, small sample sizes and inconsistent results. Summary The current literature does not strongly support any individual MAT for CUD. Psychosocial interventions, namely contingency management, have the most evidence for treatment of CUD, but it is worth seriously considering MAT for patients who do not respond well to psychosocial interventions alone given limitations in access to care, relatively low risks associated with MAT and significant morbidity associated with CUD. Further research into MAT for CUD is necessary, as the combination of MAT and psychosocial interventions may be better than either alone.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available